• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环非编码 RNA 在慢性肾脏病及其并发症中的作用。

Circulating non-coding RNAs in chronic kidney disease and its complications.

机构信息

Department of Internal Medicine (Nephrology), Leiden University Medical Center, Leiden, the Netherlands.

Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Nat Rev Nephrol. 2023 Sep;19(9):573-586. doi: 10.1038/s41581-023-00725-w. Epub 2023 Jun 7.

DOI:10.1038/s41581-023-00725-w
PMID:37286733
Abstract

Post-transcriptional regulation by non-coding RNAs (ncRNAs) can modulate the expression of genes involved in kidney physiology and disease. A large variety of ncRNA species exist, including microRNAs, long non-coding RNAs, piwi-interacting RNAs, small nucleolar RNAs, circular RNAs and yRNAs. Despite early assumptions that some of these species may exist as by-products of cell or tissue injury, a growing body of literature suggests that these ncRNAs are functional and participate in a variety of processes. Although they function intracellularly, ncRNAs are also present in the circulation, where they are carried by extracellular vesicles, ribonucleoprotein complexes or lipoprotein complexes such as HDL. These systemic, circulating ncRNAs are derived from specific cell types and can be directly transferred to a variety of cells, including endothelial cells of the vasculature and virtually any cell type in the kidney, thereby affecting the function of the host cell and/or its response to injury. Moreover, chronic kidney disease itself, as well as injury states associated with transplantation and allograft dysfunction, is associated with a shift in the distribution of circulating ncRNAs. These findings may provide opportunities for the identification of biomarkers with which to monitor disease progression and/or the development of therapeutic interventions.

摘要

非编码 RNA(ncRNA)的转录后调控可以调节参与肾脏生理和疾病的基因的表达。存在大量的 ncRNA 种类,包括 microRNAs、长非编码 RNA、piwi 相互作用 RNA、小核仁 RNA、环状 RNA 和 yRNA。尽管早期的假设认为这些物种中的一些可能是细胞或组织损伤的副产品,但越来越多的文献表明这些 ncRNA 是具有功能的,并参与了多种过程。尽管它们在细胞内发挥作用,但 ncRNA 也存在于循环中,它们可以通过细胞外囊泡、核糖核蛋白复合物或脂蛋白复合物(如高密度脂蛋白)携带。这些系统的、循环的 ncRNA 来自特定的细胞类型,可以直接转移到多种细胞中,包括血管内皮细胞和肾脏中的几乎任何细胞类型,从而影响宿主细胞的功能和/或其对损伤的反应。此外,慢性肾脏病本身以及与移植和同种异体移植物功能障碍相关的损伤状态,与循环 ncRNA 分布的改变有关。这些发现可能为识别生物标志物提供机会,以便监测疾病进展和/或治疗干预的发展。

相似文献

1
Circulating non-coding RNAs in chronic kidney disease and its complications.循环非编码 RNA 在慢性肾脏病及其并发症中的作用。
Nat Rev Nephrol. 2023 Sep;19(9):573-586. doi: 10.1038/s41581-023-00725-w. Epub 2023 Jun 7.
2
Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.非编码 RNA 作为液体活检中的生物标志物,特别关注泌尿系统恶性肿瘤中外泌体。
Expert Rev Mol Diagn. 2020 Feb;20(2):151-167. doi: 10.1080/14737159.2019.1665998. Epub 2019 Sep 18.
3
Non-coding RNAs in kidney injury and repair.非编码 RNA 在肾损伤与修复中的作用
Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C177-C188. doi: 10.1152/ajpcell.00048.2019. Epub 2019 Apr 10.
4
Non-coding RNA in cancer.癌症中的非编码 RNA
Essays Biochem. 2021 Oct 27;65(4):625-639. doi: 10.1042/EBC20200032.
5
Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma.垂体腺瘤中的非编码RNA和外泌体非编码RNA
Pathol Res Pract. 2023 Aug;248:154649. doi: 10.1016/j.prp.2023.154649. Epub 2023 Jun 28.
6
Non-coding RNAs in cardiovascular cell biology and atherosclerosis.非编码 RNA 在心血管细胞生物学和动脉粥样硬化中的作用。
Cardiovasc Res. 2019 Oct 1;115(12):1732-1756. doi: 10.1093/cvr/cvz203.
7
Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential.非编码 RNA 在人类癌症和其他疾病中的作用:诊断潜力概述。
Int J Mol Sci. 2023 Nov 11;24(22):16213. doi: 10.3390/ijms242216213.
8
Non-coding RNAs: regulators of disease.非编码 RNA:疾病的调控者。
J Pathol. 2010 Jan;220(2):126-39. doi: 10.1002/path.2638.
9
Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases.探索微小RNA和长链非编码RNA在肾脏疾病中的治疗意义。
Genes (Basel). 2024 Jan 19;15(1):123. doi: 10.3390/genes15010123.
10
Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders.非编码 RNA 在干细胞发育和骨疾病治疗中的差异表达。
Cells. 2023 Apr 14;12(8):1159. doi: 10.3390/cells12081159.

引用本文的文献

1
Association of oxidative balance score with all-cause and cardiovascular mortality among patients with cardio-renal-metabolic disease.氧化平衡评分与心肾代谢疾病患者全因死亡率和心血管死亡率的关联。
Front Nutr. 2025 Jun 25;12:1618184. doi: 10.3389/fnut.2025.1618184. eCollection 2025.
2
Molecular Crosstalk Between SIRT1, Wnt/β-Catenin Signaling, and Inflammatory Pathways in Renal Transplant Rejection: Role of miRNAs, lncRNAs, IL-1, IL-6, and Tubulointerstitial Inflammation.肾移植排斥反应中SIRT1、Wnt/β-连环蛋白信号通路与炎症通路之间的分子串扰:微小RNA、长链非编码RNA、白细胞介素-1、白细胞介素-6及肾小管间质炎症的作用
Medicina (Kaunas). 2025 Jun 11;61(6):1073. doi: 10.3390/medicina61061073.
3

本文引用的文献

1
Exosome‑encapsulated miR‑26a attenuates aldosterone‑induced tubulointerstitial fibrosis by inhibiting the CTGF/SMAD3 signaling pathway.外泌体包裹的 miR-26a 通过抑制 CTGF/SMAD3 信号通路减轻醛固酮诱导的肾小管间质纤维化。
Int J Mol Med. 2023 Feb;51(2). doi: 10.3892/ijmm.2022.5214. Epub 2022 Dec 16.
2
Cell-specific targeting of extracellular vesicles through engineering the glycocalyx.通过工程化细胞外囊泡的糖萼实现细胞特异性靶向。
J Extracell Vesicles. 2022 Dec;11(12):e12290. doi: 10.1002/jev2.12290.
3
Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM.
Peripheral blood RNA modifications as a novel diagnostic signature for polycystic ovary syndrome.
外周血RNA修饰作为多囊卵巢综合征的一种新型诊断标志物
Sci China Life Sci. 2025 Jun 3. doi: 10.1007/s11427-024-2913-7.
4
Circ-0069561 as a novel diagnostic biomarker for progression of diabetic kidney disease.环状RNA-0069561作为糖尿病肾病进展的新型诊断生物标志物
Ren Fail. 2025 Dec;47(1):2490200. doi: 10.1080/0886022X.2025.2490200. Epub 2025 Apr 22.
5
The significance of small noncoding RNAs in the pathogenesis of cardiovascular diseases.小非编码RNA在心血管疾病发病机制中的意义。
Genes Dis. 2024 May 30;12(4):101342. doi: 10.1016/j.gendis.2024.101342. eCollection 2025 Jul.
6
The gut-kidney axis is regulated by astragaloside IV to inhibit cyclosporine A-induced nephrotoxicity.黄芪甲苷通过调节肠-肾轴来抑制环孢素A诱导的肾毒性。
Front Pharmacol. 2025 Jan 27;16:1518481. doi: 10.3389/fphar.2025.1518481. eCollection 2025.
7
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease.综合多组学分析:一种增进对糖尿病肾病理解的方法。
Diabet Med. 2025 Feb;42(2):e15447. doi: 10.1111/dme.15447. Epub 2024 Oct 26.
8
The emerging modulators of non-coding RNAs in diabetic wound healing.非编码 RNA 在糖尿病创面愈合中新兴的调控分子。
Front Endocrinol (Lausanne). 2024 Oct 8;15:1465975. doi: 10.3389/fendo.2024.1465975. eCollection 2024.
9
The role of epigenetics in women's reproductive health: the impact of environmental factors.表观遗传学在女性生殖健康中的作用:环境因素的影响。
Front Endocrinol (Lausanne). 2024 Sep 13;15:1399757. doi: 10.3389/fendo.2024.1399757. eCollection 2024.
10
The Role of the MiR-181 Family in Hepatocellular Carcinoma.miR-181 家族在肝细胞癌中的作用。
Cells. 2024 Jul 31;13(15):1289. doi: 10.3390/cells13151289.
骨髓间充质干细胞来源的外泌体 miR-21a-5p 通过靶向 PFKM 减弱糖酵解缓解肾纤维化。
Cell Death Dis. 2022 Oct 17;13(10):876. doi: 10.1038/s41419-022-05305-7.
4
Circulating and urinary microRNAs profile for predicting renal recovery from severe acute kidney injury.用于预测严重急性肾损伤后肾脏恢复情况的循环和尿液微小RNA谱
J Intensive Care. 2022 Sep 30;10(1):45. doi: 10.1186/s40560-022-00637-0.
5
Small non-coding RNA therapeutics for cardiovascular disease.小非编码 RNA 治疗心血管疾病。
Eur Heart J. 2022 Nov 14;43(43):4548-4561. doi: 10.1093/eurheartj/ehac463.
6
MicroRNAs in kidney injury and disease.微小 RNA 与肾脏损伤和疾病
Nat Rev Nephrol. 2022 Oct;18(10):643-662. doi: 10.1038/s41581-022-00608-6. Epub 2022 Aug 16.
7
Exosomal miR-7002-5p derived from highglucose-induced macrophages suppresses autophagy in tubular epithelial cells by targeting Atg9b.高糖诱导的巨噬细胞来源的外泌体 miR-7002-5p 通过靶向 Atg9b 抑制肾小管上皮细胞自噬。
FASEB J. 2022 Sep;36(9):e22501. doi: 10.1096/fj.202200550RR.
8
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States.美国针对奥密克戎变异株新冠病毒相关住院治疗的初始系列疫苗和加强剂量的疫苗效力
medRxiv. 2022 Jun 14:2022.06.09.22276228. doi: 10.1101/2022.06.09.22276228.
9
GABA alleviates high glucose-induced podocyte injury through dynamically altering the expression of macrophage M1/M2-derived exosomal miR-21a-5p/miR-25-3p.GABA 通过动态改变巨噬细胞 M1/M2 来源的外泌体 miR-21a-5p/miR-25-3p 的表达缓解高糖诱导的足细胞损伤。
Biochem Biophys Res Commun. 2022 Aug 27;618:38-45. doi: 10.1016/j.bbrc.2022.06.019. Epub 2022 Jun 9.
10
Bone marrow mesenchymal stem cell-derived extracellular vesicles containing miR-181d protect rats against renal fibrosis by inhibiting KLF6 and the NF-κB signaling pathway.骨髓间充质干细胞来源的细胞外囊泡含有 miR-181d,通过抑制 KLF6 和 NF-κB 信号通路来保护大鼠免受肾纤维化。
Cell Death Dis. 2022 Jun 7;13(6):535. doi: 10.1038/s41419-022-04875-w.